Selected passages from the FDA letter
Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.
Passage 1The labels of the welloStationX devices do not bear such a UDI.
Passage 2has not submitted to GUDID any information required by 21 CFR Part 830, subpart E, respecting these devices.
Citations in the original letter
As cited in this historical letter, not a statement of current regulatory requirements.
- 21 CFR 801.20(a)
- 21 CFR 801.3
- 21 CFR 801.40(a)(1)
- 21 CFR 801.40(a)(2)
- 21 CFR 801
- 21 CFR 830
- 21 CFR 830.300(a)
- 21 CFR 830.3